The possible role of cytokines in chemotherapy-induced cognitive deficits

Advances in Experimental Medicine and Biology

Volumn 678, Issue , 2010, Pages 119-123

  Myers, Jamie S ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF NURSING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; CISPLATIN; CYTOKINE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; PACLITAXEL; TUMOR NECROSIS FACTOR; VINCRISTINE; AUTACOID;

ARTICLE; BLOOD BRAIN BARRIER; CANCER CHEMOTHERAPY; COGNITIVE DEFECT; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; FLU LIKE SYNDROME; HUMAN; ILLNESS BEHAVIOR; IMMUNE RESPONSE; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN FUNCTION; QUALITY OF LIFE; SIDE EFFECT; SIGNAL TRANSDUCTION; TUMOR PROMOTION; CHEMICALLY INDUCED DISORDER; DRUG THERAPY; IMMUNOLOGY; METABOLISM; NEOPLASM;

ANTINEOPLASTIC AGENTS; COGNITION DISORDERS; CYTOKINES; DRUG THERAPY; HUMANS; ILLNESS BEHAVIOR; INFLAMMATION MEDIATORS; NEOPLASMS;

EID: 77956642241     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-6306-2_15     Document Type: Article

References (32)

1. Maier SF, Watkins LR. Immune-to-central nervous system communication and its role in modulating pain and cognition: implications for cancer and cancer treatment. Brain Behav Immun 2003; 17(Suppl 1):S125-131. (Pubitemid 36298525)
2. Miller AH. Cytokines and sickness behavior: implications for cancer care and control. Brain Behav Immun 2003; 17:S132-134. (Pubitemid 36298526)
3. Niiya M, Niiya K, Kiguchi T et al. Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung cancer cells. Cancer Chemother Pharmacol 2003; 52:391-398. (Pubitemid 37363612)
4. Wichmann MW, Meyer G, Adam M et al. Detrimental immunologc efects of preoperative chemoradiotherapy in advanced rectal cancer. Dis Colon Rectum 2003; 46:875-887. (Pubitemid 36875481)
5. Zaks-Zilberman M, Zaks TZ, Vogel SN. Induction of proinflammatory and chemokine genes by lipopolysaccharide and paclitaxel (Taxol) in murine and human breast cancer cell lines. Cytokine 2001; 15(3):156-165. (Pubitemid 34587497)
6. Hart BL. Biological basis of the behavior of sick animals. Neurosci Biobehav Rev 1988; 12(2):123-137. (Pubitemid 19268745)
7. Wood LJ, Nail LM, Gilster A et al. Cancer chemotherapy-related symptoms: Evidence to suggest a role for proinflammatory cytokines. Oncolog Nursing Forum 2006; 33:535-542. (Pubitemid 44870222)
8. Decker J. Cytokines. 2006. http://www.microvet.arizona.edu/courses/ MIC419/Tutorials/cytokines.html.Accessed 2009.
9. Maier SF, Watkins LR. Cytokines for psychologists: implications of bi-directional immune-to-brain communication for understanding behavior, mood and cognition. Psychology Review 1998; 105(1):83-107. (Pubitemid 128459559)
10. Ebrahimi B, Tucker SL, Li D et al. Cytokines in pancreatic carcinoma: Correlation with phenotypic characteristics and prognosis. Cancer 2004; 101:2727-2736. (Pubitemid 39603180)
11. Kronfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 2000; 157(5):683-694. (Pubitemid 30249643)
12. Lee B, Dantzer R, Langley KE et al. A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation 2004; 11:279-282.
13. Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005; 7:211-217. (Pubitemid 40568680)
14. Cleeland CS, Bennett GJ, Dantzer R et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immonologic model of cancer symptoms. Cancer 2003; 97:2919-2925. (Pubitemid 36605163)
15. Maier SF. Bi-directional immune-brain communication: implications for understanding stress, pain and cognition. Brain Behav Immun 2003; 17(2):69-85. (Pubitemid 36369416)
16. Ahles TA, Saykin A. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 2007; 7:192-201.
17. Chen Y, Jungsuwadee P, Vore M et al. Collateral damage in cancer chemotherapy: Oxidative stress in nontargeted tissues. Mol Interv 2007; 7(3):147-155.
18. Tangpong J, Cole MP, Sultana R et al. Adriamycin-mediated nitration of manganese superoxide dismutase in the central nervous system: Insight into the mechanism of chemobrain. J Neurochem 2007; 100(1):191-201. (Pubitemid 46090774)
19. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci 2001; 933:222-234. (Pubitemid 32386037)
20. Harvey PO, Pruessner J, Czechowska Y et al. Individual differences in trait anhedonia: a structural and functional magnetic resonance imaging study in nonclinical subjects. Mol Psychiatry 2007; Epub ahead of print.
21. Pollmacher T, Haack M, Schuld A et al. Low levels of circulating inflammatory cytokines- do they affect human brain functions? Brain Behav Immun 2002; 16:525-532. (Pubitemid 35333732)
22. De La Garza R. Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia. Neurosci Biobehav Rev 2005; 29:761-770.
23. Johnson RW. The concept of sickness behavior: a brief chronological account of four key discoveries. Vet Immunol Immunopathol 2002; 87(3-4):443-450. (Pubitemid 34665274)
24. Haddad JJ, Saade NE, Safieh-Garabedian B. Cytokines and neuro-immune endocrine interactions: a role for the hypothalamic-pituitary-adrenal revolving axis. J Neuroimmunol 2003; 133(1-2):1-19.
25. Larson SJ. Behavioral and motivational effects of immune-system activation. J Gen Psychol2002; 129(4):401-414.
26. Kelley KW, Bluthe RM, Dantzer R et al. Cytokine-induced sickness behavior. Brain Behav Immun 2003; 17(Suppl 1):S112-118. (Pubitemid 36298523)
27. Dantzer R. Cytokine-induced sickness behavior: a neuroimmune response to activation of innate immunity. Eur J Pharmacol 2004; 500(1-3):399-411. (Pubitemid 39304023)
28. Illman J, Corringham R, Robinson D et al. Are inflammatory cytokines the common link between cancer-associated cachexia and depression? J Support Oncol 2005; 3(1):37-50. (Pubitemid 41029582)
29. Barsevik AM. The elusive concept of the symptom cluster. Oncol Nurs Forum 2007; 34:971-980.
30. Dodd M, Miaskowski C, Paul SM. Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 2001; 28:465-470.
31. Kim HJ, McGuire DB, Tulman L. Symptom clusters: Concept analysis and clinical implications for cancer nursing. Cancer Nurs 2005; 28:270-282.
32. Fleishman SB. Treatment of symptom clusters: Pain, depression and fatigue. J Natl Cancer Inst Monogr. 2004;(32):119-23.